A Strategy to Extend to Lives of Those Waiting for a Donor Liver  

There is a significant need for a medical device that can reduce and control the presence of inflammatory cytokines and toxins from the bloodstream. Based on these requirements, Sigyn Therapy is a candidate strategy to stabilize or extend the life of a patient prior to the identification of a matched liver for transplantation.  Otherwise known as a bridge-to-liver transplant. In 2017, 8,082 U.S. patients received a liver transplant and 13,885 patients were on the waiting list for a liver transplant. The average cost associated with a liver transplant is $577,100 in the U.S.